Invenomic Capital Management’s illumin Holdings Inc. Common Shares ILLM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-97,700
Closed -$155K 161
2023
Q1
$155K Sell
97,700
-89,936
-48% -$150K 0.01% 140
2022
Q4
$289K Sell
187,636
-599,848
-76% -$987K 0.02% 139
2022
Q3
$1.37M Sell
787,484
-21,946
-3% -$51.3K 0.12% 131
2022
Q2
$1.9M Buy
+809,430
New +$2.18M 0.13% 125

Other funds holding ILLM

Invenomic Capital Management's ILLM Position: Q2 2023 in Review

Invenomic Capital Management sold out of illumin Holdings Inc. Common Shares (ILLM) in Q2 2023, closing a stake of 97,700 shares — an estimated $155K sold.

Invenomic Capital Management first reported a position in ILLM in Q2 2022 and held it in 4 quarters. The position peaked at $1.9M in Q2 2022. 39 funds tracked by Wall St. Rank hold ILLM as of Q2 2023.

  • Invenomic Capital Management reported no remaining illumin Holdings Inc. Common Shares position as of Q2 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 97,700 illumin Holdings Inc. Common Shares shares in Q2 2023, an estimated $155K.
  • Invenomic Capital Management first reported a position in illumin Holdings Inc. Common Shares in Q2 2022 and held it in 4 quarters.
  • Invenomic Capital Management's illumin Holdings Inc. Common Shares position peaked at $1.9M in Q2 2022.
  • 39 funds tracked by Wall St. Rank held illumin Holdings Inc. Common Shares as of Q2 2023.

Based on Invenomic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.